Mircera and Hyperventilation - a phase IV clinical study of FDA data

Summary:

Hyperventilation is reported as a side effect among people who take Mircera (methoxy polyethylene glycol-epoetin beta), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Venofer, and have Anaemia.

The phase IV clinical study analyzes which people have Hyperventilation when taking Mircera. It is created by eHealthMe based on reports of 10,311 people who have side effects when taking Mircera from the FDA, and is updated regularly.

What is Mircera?

Mircera has active ingredients of methoxy polyethylene glycol-epoetin beta. eHealthMe is studying from 10,321 Mircera users. Check the latest studies of Mircera.

What is Hyperventilation?

Hyperventilation is found to be associated with 854 drugs and 1,431 conditions by eHealthMe. Check the latest studies of Hyperventilation.

On Nov, 11, 2025

10,311 people reported to have side effects when taking Mircera.
Among them, 11 people (0.11%) have Hyperventilation.

Among these 11 people:

How long have people been on Mircera when they have Hyperventilation? *

What is the gender of people who have Hyperventilation when taking Mircera? *

female: 81.82 %
male: 18.18 %

What is the age of people who have Hyperventilation when taking Mircera? *

What are other drugs people take besides Mircera? *

What are other side effects people have besides Hyperventilation? *

Skin Blushing/flushing (a sudden reddening of the face, neck): 10 people, 90.91%
Dyspnea (difficult or laboured breathing): 8 people, 72.73%
Chest Pain: 7 people, 63.64%
Arrhythmias (irregular heartbeat): 6 people, 54.55%
Respiratory Distress (difficulty in breathing): 5 people, 45.45%
Nausea (feeling of having an urge to vomit): 5 people, 45.45%
Wheezing (a high-pitched whistling sound made while you breath): 4 people, 36.36%
Feeling Hot: 4 people, 36.36%
Urticaria (rash of round, red welts on the skin that itch intensely): 4 people, 36.36%
Stress And Anxiety: 4 people, 36.36%

What are the existing conditions these people have? *

Anaemia (lack of blood): 6 people, 54.55%
Nephrogenic Anaemia (anaemia due to kidney disease): 3 people, 27.27%
Iron Deficiency Anaemia: 3 people, 27.27%
Iron Deficiency: 1 person, 9.09%
Blood Phosphorus Abnormal: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Mircera and have Hyperventilation?

- Check whether Hyperventilation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mircera:

Mircera (10,321 reports)

Hyperventilation treatments and more:

Hyperventilation (8,309 reports)

How severe was Hyperventilation and when was it recovered:

Hyperventilation in Mircera

Expand to all the drugs that have ingredients of methoxy polyethylene glycol-epoetin beta:

Hyperventilation and drugs with ingredients of methoxy polyethylene glycol-epoetin beta

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mircera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperventilation:

Hyperventilation (854 drugs)

Browse all the conditions that are associated with Hyperventilation:

Hyperventilation (1,431 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methoxy polyethylene glycol-epoetin beta (the active ingredients of Mircera) and Mircera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.